For the Quarter Ending March 2026
Sulfamethoxazole Prices in North America
- In United States, the Sulfamethoxazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- The Sulfamethoxazole Production Cost Trend increased during January-March 2026 as producer prices rose 4.0% year-over-year.
- Toluene and aniline feedstock costs surged in March 2026, elevating the overall Sulfamethoxazole Price Index.
- The Sulfamethoxazole Demand Outlook strengthened in Q1 2026, supported by a 4.0% year-over-year retail sales increase.
- Consumer confidence reached 91.8 in March 2026, sustaining out-of-pocket healthcare spending and broad-spectrum antibiotic demand.
- Industrial production grew 0.7% year-over-year in March 2026, while the Manufacturing Index expanded in February 2026.
- A stable 4.3% unemployment rate in March 2026 maintained healthcare coverage, supporting consistent prescription fulfillment.
- Consumer prices increased 3.3% year-over-year in March 2026, raising transportation and logistics costs for pharmaceuticals.
- The Sulfamethoxazole Price Forecast remained elevated in Q1 2026 due to severe import rerouting and delays.
Why did the price of Sulfamethoxazole change in March 2026 in North America?
- Toluene and aniline raw material pricing faced upward pressure in Q1 2026 amid energy volatility.
- Global active pharmaceutical ingredient supply tightened in Q1 2026 due to geopolitical transit route disruptions.
- Downstream demand for broad-spectrum antibiotics strengthened in Q1 2026 due to seasonal infection treatment protocols.
Sulfamethoxazole Prices in APAC
- In China, the Sulfamethoxazole Price Index rose quarter-over-quarter in Q1 2026, driven by escalating upstream benzene feedstock costs.
- The Sulfamethoxazole Production Cost Trend increased in March 2026 as the Producer Price Index rose 0.5% year-over-year.
- The Sulfamethoxazole Demand Outlook remained stable in March 2026, supported by a 1.0% year-over-year Consumer Price Index increase.
- Industrial production grew 5.7% year-over-year in March 2026, ensuring robust baseline supply for Sulfamethoxazole pharmaceutical formulation end-uses.
- An urban unemployment rate of 5.4% in March 2026 pressured veterinary Sulfamethoxazole demand as farmers reduced prophylactic usage.
- Retail sales grew 1.7% year-over-year in March 2026, reflecting softer consumer spending on retail veterinary Sulfamethoxazole products.
- Domestic chemical inventories tightened in March 2026 as Chinese refiners prioritized fuel production over Sulfamethoxazole intermediate chemical output.
- The Sulfamethoxazole Price Forecast reflected upward momentum in Q1 2026 due to inflated global pharmaceutical excipient input costs.
Why did the price of Sulfamethoxazole change in March 2026 in APAC?
- Upstream benzene feedstock costs escalated sharply following severe Middle East geopolitical disruptions in March 2026.
- Domestic chemical inventories tightened as Chinese refiners prioritized fuel production over chemical output in March 2026.
- The Producer Price Index rose 0.5% year-over-year in March 2026, pushing factory-gate manufacturing costs higher.
Sulfamethoxazole Prices in Europe
- In Germany, the Sulfamethoxazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock and energy costs.
- The Sulfamethoxazole Production Cost Trend increased in March 2026 as the 2.7% CPI YoY elevated operational expenses.
- Despite a -0.2% PPI YoY in March 2026, upstream naphtha and benzene feedstock costs jumped significantly.
- The Manufacturing Index expanded in March 2026, tightening fine chemical supplies and supporting the Sulfamethoxazole Demand Outlook.
- Retail sales grew 0.7% and unemployment stayed at 4.2% in February 2026, sustaining human healthcare medication demand.
- Consumer confidence dropped to -24.7 in March 2026, negatively impacting discretionary spending on veterinary pharmaceutical end-uses.
- Chemical tanker freight rates soared in March 2026 due to Middle East conflicts, disrupting European supply chains.
- The Sulfamethoxazole Price Forecast indicated continued upward pressure throughout Q1 2026 due to tightened regional production capacity.
Why did the price of Sulfamethoxazole change in March 2026 in Europe?
- Benzene and naphtha feedstock costs jumped sharply in Europe during March 2026, elevating production expenses.
- European natural gas prices surged significantly in March 2026, increasing energy costs for chemical synthesis.
- Middle East conflicts disrupted supply chains, causing chemical freight rates to soar in March 2026.
For the Quarter Ending December 2025
Sulfamethoxazole Prices in APAC
- In China, the Sulfamethoxazole Price Index declined quarter-over-quarter in Q4 2025, due to weak demand and market oversupply.
- Sulfamethoxazole production costs decreased in Q4 2025, as producer prices declined by 1.9% year-over-year in December 2025.
- Sulfamethoxazole demand outlook was subdued, with retail sales growing only 0.9% year-over-year in December 2025.
- The Manufacturing Index expanded in December 2025, indicating growth in the broader manufacturing sector.
- Industrial production increased by 5.2% year-over-year in December 2025, supporting chemical input demand.
- Benzene feedstock costs declined in October 2025, contributing to lower Sulfamethoxazole manufacturing expenses.
- East China port acetone inventories significantly climbed in October 2025, reflecting persistent market oversupply.
- Weak consumer inflationary pressure, with CPI at 0.8% year-over-year in December 2025, impacted demand.
- A moderate unemployment rate of 5.1% in December 2025 influenced consumer disposable income.
Why did the price of Sulfamethoxazole change in December 2025 in APAC?
- Producer prices declined by 1.9% in December 2025, reducing Sulfamethoxazole manufacturing costs.
- Weak demand for acetone, a key precursor, persisted in October 2025, impacting Sulfamethoxazole.
- East China port acetone inventories significantly climbed in October 2025, contributing to oversupply.
Sulfamethoxazole Prices in North America
- In United States, the Sulfamethoxazole Price Index rose quarter-over-quarter in Q4 2025, driven by intensifying production costs and moderate demand.
- Sulfamethoxazole production costs faced upward pressure in Q4 2025, as general chemical manufacturing expenses intensified.
- The Producer Price Index (PPI) increased 3.0% year-over-year in November 2025, reflecting rising input costs.
- Consumer Price Index (CPI) rose 2.7% year-over-year in December 2025, indicating general inflation affecting raw materials.
- Demand for Sulfamethoxazole was supported by growing pharmaceutical production and sales globally in 2025.
- Industrial production increased 2.0% year-over-year in December 2025, indirectly bolstering healthcare spending.
- US Henry Hub natural gas spot prices gradually rose in late 2025, impacting Sulfamethoxazole energy costs.
- US chemical imports and exports were projected to reach their lowest levels since 2020/2021 in 2025.
- Industry-wide destocking cycles were waning in 2025, influencing inventory levels for related chemicals.
Why did the price of Sulfamethoxazole change in December 2025 in North America?
- Sulfamethoxazole production costs rose due to a 3.0% PPI increase in November 2025 and higher energy costs.
- Demand was supported by a 3.3% rise in retail sales in November 2025 and growing pharmaceutical sector activity.
- Reduced US chemical trade volumes in 2025, influenced by geopolitical tensions, impacted Sulfamethoxazole supply.
Sulfamethoxazole Prices in Europe
- In Germany, the Sulfamethoxazole Price Index remained stable in Q4 2025, amidst contracting manufacturing activity in December 2025.
- Sulfamethoxazole production costs declined in December 2025, driven by a 2.5% year-over-year decrease in producer prices.
- Demand for Sulfamethoxazole was supported by positive indicators within Germany's pharmaceutical sector in December 2025.
- The Sulfamethoxazole Price Forecast suggests stability, as moderate 1.8% inflation in December 2025 balanced lower input costs.
- Industrial production in Germany inched up by 0.8% year-over-year in October 2025, indirectly supporting chemical demand.
- Weak export volumes for German chemical and pharmaceutical industries hampered trade flows in December 2025.
- High industrial natural gas costs throughout 2025 challenged Sulfamethoxazole production competitiveness.
- Consumer confidence declined significantly to -17.5 in December 2025, indirectly influencing healthcare spending.
- Germany's Manufacturing Index showed a contracting trend in December 2025, signaling a weaker economic outlook.
Why did the price of Sulfamethoxazole change in December 2025 in Europe?
- Producer prices declined by 2.5% year-over-year in December 2025, reducing Sulfamethoxazole manufacturing costs.
- Weak export volumes for German chemical and pharmaceutical industries hampered trade in December 2025.
- High industrial natural gas costs persisted throughout 2025, impacting overall production expenses.
For the Quarter Ending September 2025
Sulfamethoxazole Prices in North America
- In United States, Sulfamethoxazole Price Index fell in Q3 2025, due to oversupply and deteriorating chemical demand.
- Production costs for Sulfamethoxazole rose in Q3 2025, with PPI up 2.6% in August and CPI up 3.0% in September.
- Medical sector demand strengthened during H2 2025, providing support for Sulfamethoxazole consumption.
- Industrial production grew only 0.1% in September 2025, reflecting broader market weakness and falling new orders.
- Chemical industry inventories tightened in Q3 2025, driven by accelerating destocking efforts.
- US chemical import and export volumes contracted in 2025, influenced by tariff friction during Q3 2025.
- Natural gas prices inched up in September 2025, while crude oil prices weakened in July-August 2025.
- Strong retail sales, up 5.42% in September 2025, and low 4.3% unemployment supported human pharmaceutical demand.
- Consumer confidence declined to 94.2 in September 2025, signaling potential headwinds for overall economic activity.
Why did the price of Sulfamethoxazole change in September 2025 in North America?
- Oversupply in the chemical industry during Q3 2025 exerted downward pressure.
- Major customer market demand for chemicals deteriorated in Q3 2025, reducing new orders.
- Rising input/raw materials and energy costs in Q3 2025 increased production expenses.
Sulfamethoxazole Prices in APAC
- In China, the Sulfamethoxazole Price Index fell quarter-over-quarter, driven by weak industrial demand and falling factory-gate prices.
- Sulfamethoxazole price forecast indicates continued pressure from persistent overcapacity and pessimistic consumer confidence in September 2025.
- Sulfamethoxazole production costs saw mixed trends; benzene feedstock stabilized, but manufacturing input prices jumped in July 2025.
- Demand outlook for Sulfamethoxazole remains sustained by an aging population and chronic diseases in 2025.
- The Sulfamethoxazole Price Index faced downward pressure from -0.3% CPI and -2.3% PPI year-over-year in September 2025.
- China's Manufacturing Index contracted July-August 2025, though new orders and production expanded in September 2025.
- Retail sales grew 3.0% year-over-year in September 2025, supporting consumer spending on healthcare.
- Raw materials inventory for manufacturing remained below threshold in August and September 2025, amidst global overcapacity.
Why did the price of Sulfamethoxazole change in September 2025 in APAC?
- Weak industrial demand, reflected by a contracting Manufacturing Index in September 2025, pressured pricing.
- Falling factory-gate prices, with PPI down -2.3% year-over-year in September 2025, contributed to lower selling prices.
- Persistent global overcapacity in chemical building blocks throughout Q3 2025 created a competitive market.
Sulfamethoxazole Prices in Europe
- In Germany, the Sulfamethoxazole Price Index fell quarter-over-quarter in Q3 2025, influenced by contracting industrial production.
- Sulfamethoxazole production costs faced pressure from high energy costs and a 2.4% CPI increase in September 2025.
- Benzene feedstock costs were bearish in August 2025; the Producer Price Index decreased by 1.7% in September 2025.
- Sulfamethoxazole demand outlook was mixed; pharmaceutical sector demand strengthened in Q3 2025.
- Overall industrial demand remained weak, with German industrial production declining by 1.0% in September 2025.
- High European benzene stock levels and elevated overall chemical inventories persisted in Q3 2025.
- German chemical export orders trended weak in Q3 2025, impacted by US tariffs on pharmaceutical exports.
- Consumer confidence was negative at -23.6 index in September 2025, despite 0.8% retail sales and 3.9% unemployment.
Why did the price of Sulfamethoxazole change in September 2025 in Europe?
- Contracting manufacturing activity and 1.0% industrial production decline in September 2025 reduced overall demand.
- Bearish benzene feedstock costs in August 2025 and 1.7% PPI decrease in September 2025 eased input costs.
- Weak German export orders and increased US imports intensified competition, pressuring prices in Q3 2025.
